.jpg)
2 of Ju 2024
OmicsChart successfully completed PharmStars accelerator program, culminating in a Showcase Event in Boston, USA. This experience will enable OmicsChart to connect with leading pharma members, enhancing our commitment to advancing oncology research through innovative AI and data science solutions.
15th of June 2024
OmicsChart CEO, Tanya Aneichyk, presented our cutting-edge omics data solution at the WMF - We Make Future 2024 conference in Italy. The presentation focused on how our technology is addressing the fragmented cancer data space, and provided an opportunity to introduce our solution to a broader startup audience.
4th of June 2024
OmicsChart joined the Affiliated Companies network at the Milner Therapeutics Institute, Cambridge University, UK. This collaboration will allow OmicsChart to connect with leading academic, pharmaceutical, and biotech partners, enhancing our commitment to advancing oncology research through innovative AI and data science solutions.
16th of January 2024
OmicsChart has successfully graduated from the prestigious Techstars accelerator program, marking a milestone in its recognition for the pioneering utilization of omics data within the field of oncology research. This accomplishment not only reflects the remarkable strides made by OmicsChart, but also emphasizes the growing interest within the tech industry in the emerging domain of techbio and use of machine learning and AI for precision oncology.
9th of October 2023
OmicsChart is thrilled to be selected for Techstars Berlin 2023 Deep Tech accelerator, emphasizing its commitment to advancing precision oncology through innovative technology. This partnership promises accelerated growth, mentorship, and access to industry experts and investors, marking a significant milestone in the journey to revolutionize cancer research.
15th of August 2023
Revisiting an excellent blog post by our founder and CEO Dr Tatsiana Aneichyk on commercialization in bioinformatics research. Follow a link bellow to our Medium blog post to learn more.
28th of June 2023
OmicsChart publicly launches PREON, its flagship cancer data and biomarker discovery platform. PREON provides researchers with access to a vast repository of public cancer data, accelerating scientific discoveries and personalized cancer treatments. With its intuitive interface and advanced analytics capabilities, PREON streamlines data exploration and analysis for enhanced insights.
1st of May 2023
OmicsChart become one of the 10% of start-up's to be selected to participate in AWS Startup Loft Accelerator. The program provides support and opportunities to meet expert mentors, 1:1 consulting with AWS senior solution architects as well as AWS credits.
1st of December 2022
OmicsChart received Merck Healthcare Speed Grant to investigate molecular biomarkers of HRD in cancer patients.
5th of November 2022
OmicsChart was selected as one of the top runners for Merck KGaA 2022 Research Grant.
5th of October 2022
Start?Zuschuss is a grant by Bavarian State Ministry for Economic Affairs, Regional Development and Energy to support digitalization.
18th of June 2022
OmicsChart was selected as one of three winners, securing collaboration with Microsoft.
4th of November 2021
OmicsChart presented a pitch at the High-Tech Gründerfonds and STARTUP CREASPHERE Digital Health Pitch Day, hosted online by Plug and Play.
21st of August 2021
OmicsChart has been accepted as one of 12 participants for Biotech Bootcamp by SmiLe and BioM - a business development program for aspiring biotech entrepreneurs by Europe’s leading biotech incubators.
Patient-centric cancer data and analytics platform for translational cancer biologists.
Explore mutation and expression data in the gene of your interest, validate your data and find similar patient cohorts in thousands of patients - zero coding skills required
